We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current NBTX market cap is 140.16M. The company's latest EPS is EUR -0.8423 and P/E is -3.49.
Quarter End | |||||
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | |||||
Operating Income | |||||
Net Income |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 2.54M | 2.51M | 2.65M | 4.78M | 36.21M |
Operating Income | -46.67M | -36.39M | -52.51M | -46.47M | -26.62M |
Net Income | -50.92M | -33.59M | -47M | -57.04M | -39.7M |
Quarter End | |||||
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | |||||
Total Liabilities | |||||
Total Equity |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 56.21M | 134.03M | 101.77M | 59.77M | 93.9M |
Total Liabilities | 58.11M | 63.56M | 74.98M | 86.81M | 95.74M |
Total Equity | -1.91M | 70.47M | 26.79M | -27.05M | -1.84M |
Quarter End | |||||
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | |||||
Investing | |||||
Financing |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | -41.17M | -27.54M | -29.87M | -37.1M | -12.48M |
Investing | -1.46M | -111k | -242k | 137k | -349k |
Financing | 41.49M | 111.77M | -5.18M | -5.65M | 46.77M |
Market Cap | 140.16M |
Price to Earnings Ratio | -3.49 |
Price to Sales Ratio | 3.83 |
Price to Cash Ratio | 1.84 |
Price to Book Ratio | -75.19 |
Dividend Yield | - |
Shares Outstanding | 47.13M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.03 (1%) |
Company Name | Nanobiotix SA |
Address |
60 rue de wattignies paris, paris 75012 |
Website | https://www.nanobiotix.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions